Second season results from the Phase 3 SMART trial were presented at the 9 th RSVVW Conference and will be shared with the U.S. FDA and other regulatory authorities New data from the SMART trial in ...
Merck & Co. (NYSE: MRK) on Thursday shared positive second RSV season findings from the Phase 3 SMART trial. The results from the SMART trial were presented at the RSVVW Conference and will be shared ...
Second season results from the Phase 3 SMART trial were presented at the 9 th RSVVW Conference and will be shared with the U.S. FDA and other regulatory authorities ...
Cases of a preventable respiratory illness primarily affecting young children are on the rise in California. State health officials are urging people to take action. Respiratory syncytial virus, or ...
A Centers for Disease Control and Prevention (CDC) illustration shows “ultrastructural morphology” exhibited by coronaviruses. A novel coronavirus was identified as the cause of an outbreak of ...
TikTok, X, and Instagram are flooded with videos about a mysterious “2025 throat virus” that’s making everyone sick. The illness causes a host of debilitating symptoms including runny nose, congestion ...
Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children. But a new study led by a University of Michigan School of Public Health researcher ...
The FDA is examining the safety of shots that protect infants from respiratory syncytial virus (RSV), according to a report from Reuters. The agency has notified executives at AstraZeneca, Merck and ...
A federal vaccine advisory panel has changed its guidance for the updated COVID-19 vaccine. Instead of a universal recommendation for all Americans 6 months and older, the panel now advises that ...
It’s that time of year again when New Jersey hospitals are seeing an increase in admissions associated with COVID-19, influenza, and RSV. Since the week ending Oct. 25, hospitalizations associated ...
The respiratory syncytial virus prefusion F protein (RSVpreF) vaccine was highly effective against RSV-related acute respiratory illness (ARI) requiring emergency care or hospitalization, including in ...
Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results